PMN · ProMIS Neurosciences Inc
United States · RS rating 4 · As of 2026-11-03
| Price | 3.41 USD |
|---|---|
| 1-day change | +13.7% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 3 / 3 / 13 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 18 / 15 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -1.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +86.2% |
| Market cap (USD) | $97.6M |